Literature DB >> 21057624

LRRK2 function on actin and microtubule dynamics in Parkinson disease.

Loukia Parisiadou1, Huaibin Cai.   

Abstract

The mutations in the LRRK2 gene cause clinically typical, late-onset Parkinson disease, strengthening the idea that the familial forms of the disease represent an important tool for the study of the idiopathic forms. Despite the great effort to describe and functionally characterize the LRRK2 gene product, its physiological role remains elusive. In this article, we will discuss along with other references, our recent findings that assigned a critical role of LRRK2 protein on cytosleketal dynamics and how this direction could provide a valuable platform to further appreciate the mechanism underlying LRRK2-mediated pathophysiology of the disease.

Entities:  

Keywords:  ERM; G2019S; LRRK2; Parkinson disease; filamentous actin; golgi apparatus; microtubule; neuronal morphogenesis; phosphorylation; tubulin

Year:  2010        PMID: 21057624      PMCID: PMC2974064          DOI: 10.4161/cib.3.5.12286

Source DB:  PubMed          Journal:  Commun Integr Biol        ISSN: 1942-0889


  56 in total

1.  The role of local actin instability in axon formation.

Authors:  F Bradke; C G Dotti
Journal:  Science       Date:  1999-03-19       Impact factor: 47.728

Review 2.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

3.  Role of microtubules in the distribution of the Golgi apparatus: effect of taxol and microinjected anti-alpha-tubulin antibodies.

Authors:  J Wehland; M Henkart; R Klausner; I V Sandoval
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

4.  Selective vulnerability of dopaminergic neurons to microtubule depolymerization.

Authors:  Yong Ren; Wenhua Liu; Houbo Jiang; Qian Jiang; Jian Feng
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

Review 5.  Force generation by microtubule assembly/disassembly in mitosis and related movements.

Authors:  S Inoué; E D Salmon
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

Review 6.  LRRK2 and neurodegeneration.

Authors:  Gabriel Santpere; Isidre Ferrer
Journal:  Acta Neuropathol       Date:  2009-01-14       Impact factor: 17.088

7.  Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra.

Authors:  Baek-Soo Han; Lorraine Iacovitti; Taku Katano; Nobutaka Hattori; Wongi Seol; Kwang-Soo Kim
Journal:  Neurosci Lett       Date:  2008-07-10       Impact factor: 3.046

8.  Leucine-rich repeat kinase 2 associates with lipid rafts.

Authors:  Taku Hatano; Shin-Ichiro Kubo; Satoshi Imai; Masahiro Maeda; Kiyoshi Ishikawa; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Hum Mol Genet       Date:  2007-03-06       Impact factor: 6.150

9.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.

Authors:  S Tsukita; K Oishi; N Sato; J Sagara; A Kawai; S Tsukita
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons.

Authors:  G Paglini; P Kunda; S Quiroga; K Kosik; A Cáceres
Journal:  J Cell Biol       Date:  1998-10-19       Impact factor: 10.539

View more
  27 in total

1.  MicroRNA expression profiling of human blood monocyte subsets highlights functional differences.

Authors:  Truong-Minh Dang; Wing-Cheong Wong; Siew-Min Ong; Peng Li; Josephine Lum; Jinmiao Chen; Michael Poidinger; Francesca Zolezzi; Siew-Cheng Wong
Journal:  Immunology       Date:  2015-07       Impact factor: 7.397

2.  High-Resolution Melting Analysis as a Developed Method for Genotyping the PD Susceptibility Loci in LRRK2 Gene.

Authors:  Enzhu Jiang; Fengrui Li; Chenchen Jing; Pei Li; Honggang Cui; Baojie Wang; Mei Ding; Hao Pang
Journal:  J Clin Lab Anal       Date:  2014-05-21       Impact factor: 2.352

3.  The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease.

Authors:  Zhihua Liu; Jinwoo Lee; Scott Krummey; Wei Lu; Huaibin Cai; Michael J Lenardo
Journal:  Nat Immunol       Date:  2011-10-09       Impact factor: 25.606

4.  LRRK2 directing ER-to-Golgi transport? (ER)yES!

Authors:  Bingwei Lu
Journal:  EMBO J       Date:  2014-09-08       Impact factor: 11.598

Review 5.  LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis.

Authors:  A Raquel Esteves; Russell H Swerdlow; Sandra M Cardoso
Journal:  Exp Neurol       Date:  2014-06-04       Impact factor: 5.330

6.  Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.

Authors:  Md Shariful Islam; Hendrik Nolte; Wright Jacob; Anna B Ziegler; Stefanie Pütz; Yael Grosjean; Karolina Szczepanowska; Aleksandra Trifunovic; Thomas Braun; Hermann Heumann; Rolf Heumann; Bernhard Hovemann; Darren J Moore; Marcus Krüger
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

7.  Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.

Authors:  Guoxiang Liu; Carmelo Sgobio; Xinglong Gu; Lixin Sun; Xian Lin; Jia Yu; Loukia Parisiadou; Chengsong Xie; Namratha Sastry; Jinhui Ding; Kelly M Lohr; Gary W Miller; Yolanda Mateo; David M Lovinger; Huaibin Cai
Journal:  Hum Mol Genet       Date:  2015-06-29       Impact factor: 6.150

8.  Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export.

Authors:  Hyun Jin Cho; Jia Yu; Chengsong Xie; Parvathi Rudrabhatla; Xi Chen; Junbing Wu; Loukia Parisiadou; Guoxiang Liu; Lixin Sun; Bo Ma; Jinhui Ding; Zhihua Liu; Huaibin Cai
Journal:  EMBO J       Date:  2014-09-08       Impact factor: 11.598

9.  SEPT14 Is Associated with a Reduced Risk for Parkinson's Disease and Expressed in Human Brain.

Authors:  Liron Rozenkrantz; Ziv Gan-Or; Mali Gana-Weisz; Anat Mirelman; Nir Giladi; Anat Bar-Shira; Avi Orr-Urtreger
Journal:  J Mol Neurosci       Date:  2016-04-26       Impact factor: 3.444

10.  LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways.

Authors:  Bo Ma; Leyan Xu; Xiaodong Pan; Lixin Sun; Jinhui Ding; Chengsong Xie; Vassilis E Koliatsos; Huaibin Cai
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.